Fairscale Capital »

iShares Dow Jones US Pharm Indx shares owned by Fairscale Capital

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 303 72.56
2025-06-30 $20k 303 65.75

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
NVIDIA Corporation (NVDA)
iShares S&P NA Tech. Sec. Idx (IGM)
Apple (AAPL)
Vanguard Admiral Fds Inc equity (VOOV)
Microsoft Corporation (MSFT)
Pacer Fds Tr us cash cows 100 (COWZ)
Invesco Qqq Trust Series 1 (QQQ)
Alphabet Inc Class A cs (GOOGL)
Visa (V)
Amazon (AMZN)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Schwab Strategic Tr us dividend eq (SCHD)

View all positions for Fairscale Capital

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Morgan Stanley
Goldman Sachs Group
LPL Financial
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Brown Advisory Holdings Incorporated
Raymond James Financial
Concord Investment Counsel
Wells Fargo & Company
UBS Group
Peapack Gladstone Financial Corp
Merit Financial Group
Commonwealth Equity Services

View all funds holding iShares Dow Jones US Pharm Indx